학술논문
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
Document Type
Article
Author
Source
In The Lancet Neurology July 2012 11(7):597-604
Subject
Language
ISSN
1474-4422